Migdal Insurance & Financial Holdings Ltd. Precision Biosciences Inc Transaction History

Migdal Insurance & Financial Holdings Ltd.

  • $6.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$8.07 - $12.52 $534,952 - $829,938
-66,289 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$8.57 - $15.79 $352,544 - $649,553
41,137 Added 163.55%
66,289 $686,000
Q4 2020

Feb 08, 2021
BUY
$5.98 - $12.47 $150,408 - $313,645
25,152 New
25,152 $210,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $422M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email